Alginate-combined Cholic Acid Increased Insulin Secretion of Microencapsulated Mouse Cloned Pancreatic β Cells

References

• Boden G . Gluconeogenesis and glycogenolysis in health and diabetes. J. Investig. Med.52 (6), 375–378 (2004).
   PubMed Web of Science ®Google Scholar
• Staehr P Hother-Nielsen O Beck-Nielsen H et al. Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis. Am. J. Physiol. Endocrinol. Metab.292 (5), E1265–1269 (2007).
   PubMed Web of Science ®Google Scholar
• Krebs M Brehm A Krssak M et al. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia46 (7), 917–925 (2003).
   PubMed Web of Science ®Google Scholar
• Galassetti P Mann S Tate D Neill RA Wasserman DH Davis SN . Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise. J. Appl. Physiol.91 (1), 91–99 (2001).
   PubMed Web of Science ®Google Scholar
• Laurent D Hundal RS Dresner A et al. Mechanism of muscle glycogen autoregulation in humans. Am. J. Physiol. Endocrinol. Metab.278 (4), E663–E668 (2000).
   PubMed Web of Science ®Google Scholar
• Borghouts LB Keizer HA . Exercise and insulin sensitivity: a review. Int. J. Sports Med.21 (1), 1–12 (2000).
   PubMed Web of Science ®Google Scholar
• Hansen BF Asp S Kiens B Richter EA . Glycogen concentration in human skeletal muscle: effect of prolonged insulin and glucose infusion. Scand. J. Med. Sci. Sports.9 (4), 209–213 (1999).
   PubMed Web of Science ®Google Scholar
• Magnusson I Rothman DL Jucker B Cline GW Shulman RG Shulman GI . Liver glycogen turnover in fed and fasted humans. Am. J. Physiol.266 (5 Pt 1), E796–E803 (1994).
   PubMedGoogle Scholar
• Erecinska M Wilson DF . On the mechanism of regulation of cellular respiration. The dependence of respiration on the cytosolic [ATP], [ADP] and [PI]. Adv. Exp. Med. Biol.94, 271–278 (1977).
   PubMedGoogle Scholar
• Skamagas M Breen T LeRoith D . Update on diabetes mellitus: prevention, treatment and association with oral diseases. Oral Dis.14 (2), 105–114 (2008).
   PubMed Web of Science ®Google Scholar
• Canivell S Gomis R . Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev.13 (4–5), 403–407 (2014).
   PubMed Web of Science ®Google Scholar
• Manfredi M McCullough M Vescovi P Al-Kaarawi Z Porter S . Update on diabetes mellitus and related oral diseases. Oral Dis.10 (4), 187–200 (2004).
   PubMed Web of Science ®Google Scholar
• Control CfD, Prevention, Control CfD, Prevention . National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. US Department of Health and Human Services, Centers for Disease Control and Prevention. Atlanta, GA, USA (2011).
   Google Scholar
• Association AD . Diagnosis and classification of diabetes mellitus. Diabetes care.31 (Suppl. 1), S55–S60 (2008).
   PubMedGoogle Scholar
• Adeghate E Schattner P Dunn E . An update on the etiology and epidemiology of diabetes mellitus. Ann. NY Acad. Sci.1084 (1), 1–29 (2006).
   PubMedGoogle Scholar
• Trinanes J Salido E Fernandez J et al. Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation. Diabetes Care35 (2), 427–433 (2012).
   PubMed Web of Science ®Google Scholar
• Llaurado G Gallart L Tirado R et al. Insulin resistance, low-grade inflammation and Type 1 diabetes mellitus. Acta Diabetologica49 (1), 33–39 (2012).
   PubMed Web of Science ®Google Scholar
• Bladbjerg EM Henriksen JE Akram S Gram J . Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with Type 2 diabetes. Basic Clin. Pharmacol. Toxicol.109 (4), 266–273 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang C Lu X Tan Y et al. Diabetes-induced hepatic pathogenic damage, inflammation, oxidative stress and insulin resistance was exacerbated in zinc deficient mouse model. PLoS One7 (12), e49257 (2012).
   PubMed Web of Science ®Google Scholar
• Negrulj R Mooranian A Al-Salami H . Potentials and limitations of bile acids in Type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system. J. Endocrinol. Diabetes Mellit.1 (2), 49–59 (2013).
   Google Scholar
• Zwicker BL Agellon LB . Transport and biological activities of bile acids. Int. J. Biochem Cell Biol.45 (7), 1389–1398 (2013).
   PubMed Web of Science ®Google Scholar
• Mikov M Fawcett JP Kuhajda K Kevresan S . Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents. Eur. J. Drug Metab. Pharmacokinet.31 (3), 237–251 (2006).
   PubMed Web of Science ®Google Scholar
• Kandrac J Kevresan S Gu JK Mikov M Fawcett JP Kuhajda K . Isolation and determination of bile acids. Eur. J. Drug Metab. Pharmacokinet.31 (3), 157–177 (2006).
   PubMed Web of Science ®Google Scholar
• Houten SM Watanabe M Auwerx J . Endocrine functions of bile acids. Embo. J.25 (7), 1419–1425 (2006).
   PubMed Web of Science ®Google Scholar
• Watanabe M Houten SM Mataki C et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature439 (7075), 484–489 (2006).
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I et al. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.34 (1), 43–50 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Golocorbin-Kon S Mikov M . Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.37 (2), 99–108 (2012).
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Mikov M . Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Methods Find Exp. Clin. Pharmacol.30 (2), 107–113 (2008).
   PubMedGoogle Scholar
• Al-Salami H Butt G Tucker I Golocorbin-Kon S Mikov M . Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.37 (2), 99–108 (2012).
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I Mikov M . Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol. Rep.60 (4), 532–541 (2008).
   PubMed Web of Science ®Google Scholar
• Al-Salami H Butt G Tucker I et al. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.34 (1), 43–50 (2009).
   PubMed Web of Science ®Google Scholar
• Lalić-Popović M Vasović V Milijašević B Goločorbin-Kon S Al-Salami H Mikov M . Deoxycholic acid as a modifier of the permeation of the antidiabetic drug gliclazide through the blood brain barrier of a rat. J. Diabetes Res. doi:10.1155/2013/598603 (2013).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Mikov M Golocorbin-Kon S Arfuso F Al-Salami H . Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study. J. Microencapsul.32 (6), 589–597 (2015).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N Watts GF Arfuso F Al-Salami H . An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des. Devel. Ther.8, 1673–1683 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Al-Sallami HS et al. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. J. Microencapsul.1–6 (2014).
   Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N et al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des Devel. Ther.8, 1003 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Arfuso F Al-Salami H . Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: formulation characterization and effects on production of insulin and inflammation in a pancreatic beta-cell line. Artif. Cells Nanomed. Biotechnol.44 (7), 1642–1653 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Arfuso F Al-Salami H . The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study. Drug Deliv. and Transl. Res.5 (5), 1–12 (2015).
   PubMed Web of Science ®Google Scholar
• Negrulj R Mooranian A Chen-Tan N et al. Swelling, mechanical strength and release properties of probucol microcapsules with and without a bile acid and their potential oral delivery in diabetes. Artif. Cells Nanomed. Biotechnol.44 (5), 1290–1297 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Mathavan S et al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J. Pharm. Innov.9, 150–157 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N et al. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Des. Devel. Ther.8, 1221–1230 (2014).
   PubMed Web of Science ®Google Scholar
• Mikov M Boni NS Al-Salami H et al. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats. Eur. J. Drug Metab. Pharmacokinet.32 (1), 7–12 (2007).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N et al. Advanced bile acid-based multi-compartmental microencapsulated pancreatic β cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment. Artif. Cells Nanomed. Biotechnol.44 (2), 588–595 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Arfuso F Al-Salami H . Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β cells. Artif. Cells Nanomed. Biotechnol.44 (1), 194–200 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Mathavan S et al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug–bile acid formulations. Pharm. Dev. Technol.20 (6), 702–709 (2015).
   PubMed Web of Science ®Google Scholar
• Mooranian A Tackechi R Jamieson E Morahan G Al-Salami H . Innovative microcapsules for pancreatic beta-cells harvested from mature double-transgenic mice: cell imaging, viability, induced glucose-stimulated insulin measurements and proinflammatory cytokines analysis. Pharm. Res.34 (6), 1217–1223 (2017).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Al-Salami H Morahan G Jamieson E . Designing anti-diabetic β cells microcapsules using polystyrenic sulfonate, polyallylamine and a tertiary bile acid: morphology, bioenergetics and cytokine analysis. Biotechnology progress.32 (2), 501–509 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Arfuso F Al-Salami H . The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study. Drug Deliv. Transl. Res.5 (5), 511–522 (2015).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Al-Salami H . The effects of ionic gelation–vibrational jet flow technique in fabrication of microcapsules incorporating β-cell: applications in diabetes. Curr. Diabetes Rev.13 (1), 91–96 (2017).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N et al. Novel multicompartmental bile acid-based microcapsules for pancreatic β-cell transplantation. Xenotransplantation22, S93–S94 (2015).
   Web of Science ®Google Scholar
• Mooranian A Negrulj R Al-Salami H . Viability and topographical analysis of microencapsulated β cells exposed to a biotransformed tertiary bile acid: an ex vivo study. Int. J. Nano. Biomaterials6 (2), 74–82 (2016).
   Google Scholar
• Mooranian A Negrulj R Al-Salami H . Primary bile acid chenodeoxycholic acid-based microcapsules to examine β-cell survival and the inflammatory response. BioNanoScience6 (2), 103–109 (2016).
   Web of Science ®Google Scholar
• Mooranian A Negrulj R Al-Salami H . Alginate-deoxycholic acid interaction and its impact on pancreatic β cells and insulin secretion and potential treatment of Type 1 diabetes. J. Pharm. Innov.11 (2), 156–161 (2016).
   Web of Science ®Google Scholar
• Mooranian A Negrulj R Chen-Tan N et al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des. Devel. Ther.8, 1003–1012 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A Tackechi R Jamieson E Morahan G Al-Salami H . Innovative microcapsules for pancreatic beta-cells harvested from mature double-transgenic mice: cell imaging, viability, induced glucose-stimulated insulin measurements and proinflammatory cytokines analysis. Pharm. Res.34 (6), 1217–1223 (2017).
   PubMed Web of Science ®Google Scholar
• Khatun Z Nurunnabi M Reeck GR Cho KJ Lee YK . Oral delivery of taurocholic acid linked heparin–docetaxel conjugates for cancer therapy. J. Control Rel.170 (1), 74–82 (2013).
   PubMed Web of Science ®Google Scholar
• Wang C Li L Guan H et al. Effects of taurocholic acid on immunoregulation in mice. Int. Immunopharmacol.15 (2), 217–222 (2013).
   PubMed Web of Science ®Google Scholar
• Wu T Bound MJ Standfield SD et al. Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. Diabetes Obes. Metab.15 (5), 474–477 (2013).
   PubMed Web of Science ®Google Scholar
• Yang J Gao C . Fabrication of diverse microcapsule arrays of high density and good stability. Macromol. Rapid Commun.31 (12), 1065–1070 (2010).
   PubMed Web of Science ®Google Scholar
• Zheng G Liu X Wang X et al. Improving stability and biocompatibility of alginate/chitosan microcapsule by fabricating bi-functional membrane. Macromol. Biosci.14 (5), 655–666 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A Negrulj R Al-Salami H . The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes. J. Microencapsul.33 (6), 569–574 (2016).
   PubMed Web of Science ®Google Scholar